{"id":"W4391527561","doi":"10.1016/j.jacc.2023.12.004","title":"Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Placebo; Atrial fibrillation; Internal medicine; Stroke (engine); Apixaban; Incidence (geometry); Myocardial infarction; Hemostasis; Adverse effect; Gastroenterology; Thrombosis; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004676899,0.0006813623,0.002593873,0.0004418382,0.0003253511,0.002074135,0.0004227333,0.0008933167,0.00256504],"category_scores_gemma":[0.007386976,0.0002979681,0.002913264,0.0007262605,0.0006499676,0.001380614,0.0004957363,0.00215267,0.0002175303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005757435,"about_ca_system_score_gemma":0.0007897832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002543835,"about_ca_topic_score_gemma":0.0008546138,"domain_scores_codex":[0.997378,0.001793577,0.0002977751,0.000205841,0.0001399779,0.0001849252],"domain_scores_gemma":[0.9963876,0.001608659,0.001134427,0.0002385109,0.0001975008,0.0004332041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8002412,0.00294704,0.03833201,0.005392034,0.03413014,0.000221221,0.0002530807,0.001779196,0.003225471,0.001578713,0.007215424,0.1046845],"study_design_scores_gemma":[0.7863234,0.100904,0.07070868,0.001414207,0.02232214,0.0005403396,0.0003014673,0.001921596,0.001482778,0.002943453,0.01100301,0.0001349157],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9314122,0.05776197,0.0008575878,0.002679605,0.0007506618,0.0006683408,0.00148426,0.00006434154,0.004321097],"genre_scores_gemma":[0.9818159,0.01234186,0.0009986334,0.00130374,0.0003924126,0.0006681372,0.001587085,0.00002263089,0.0008695523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004676899,"threshold_uncertainty_score":0.02473408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05080591876452185,"score_gpt":0.3606553322406735,"score_spread":0.3098494134761517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}